U.S. Communications Stock News

Par Pacific Holdings (PARR) remains unprofitable, but has managed to cut its losses at an impressive clip of 41.2% per year over the past five years. Investors are eyeing a projected 0.4% annual revenue decline over the next three years and continue to grapple with both negative net profit margins and ongoing poor earnings quality, as the company shows no signs of recent profitability to benchmark against previous years. With margins under pressure, the latest results set the stage for a key...

Berry (BRY) has become profitable over the past five years, reporting an average earnings growth of 41.6% per year. Looking ahead, earnings are expected to surge another 159.2% annually, but revenue is forecast to decline at an average pace of -1.1% per year for the next three years. The company also recorded a one-off loss of $3.9 million in the most recent financial year, tempering the near-term earnings outlook. Investors will be weighing this mix of rapid projected earnings growth and...

Scotts Miracle-Gro (SMG) reported earnings that finally swung into profitability over the last year, with EPS growth now forecast at 12.58% per year. Despite this turnaround, the company’s earnings have been on a tough path, declining at an average annual rate of 45.6% over the past five years. Recent results were impacted by a $136.1 million one-off loss. Revenue growth is expected to lag behind the broader market at 1.9% per year. Shares look expensive at a 60.9x price-to-earnings ratio...

Braemar Hotels & Resorts (BHR) remains unprofitable, with no improvement in its net profit margin over the last year. Over a five-year stretch, however, the company has steadily narrowed its losses at a rate of 7.3% per year. Revenue is forecast to grow at just 0.9% annually, compared to the broader US market’s projected 10.5% growth. In this operational context, BHR’s price-to-sales ratio of 0.2x stands out as especially low relative to both the industry and peers. The share price of $2.58...

Teva Pharmaceutical Industries (TEVA) is currently unprofitable, but the company has managed to trim its losses by 28.6% per year over the past five years. Revenue is forecast to grow at 2.8% per year, which is well below the US pharmaceutical market average of 10.5%. Earnings are expected to jump 19.73% annually, with the company projected to become profitable within three years. With shares trading at a significant discount compared to fair value and peers, the improving earnings outlook...

Johnson Controls International (JCI) posted a net profit margin of 8.5%, a significant jump from 5.9% last year, as earnings surged 75.6% over the past twelve months. While both revenue and earnings are projected to keep rising, with revenues at 4.8% and earnings at 7.7% per year, these growth rates are expected to trail the wider US market. Alongside these headline results, investors are weighing strong recent profit momentum against a relatively steep valuation premium in the sector. See...

Owens Corning (OC) is forecasting annual earnings growth of 20.4%, outpacing the broader US market’s expected 16% per year, but revenue is set to rise by just 1.5% per year compared to the market’s 10.5%. Net profit margin dropped to 6% from 10.8% last year, with the most recent numbers impacted by a one-off $675 million loss. Investors are watching closely as the company now trades at a P/E of 13.2x, well below both the US Building industry average and its peers, and its current share price...

Aviat Networks (AVNW) posted a net profit margin of 0.3% for the most recent period, dipping from last year’s 2.6%, as a $3.6 million one-off loss weighed on results. While annual earnings have declined at a steep 55.2% rate over the past five years, the company is still profitable, and earnings are forecast to rebound sharply with 37.3% annual growth expected going forward. For investors, the stock’s low price-to-sales multiple and strong earnings growth outlook shape an interesting story...

XPEL (XPEL) posted revenue growth forecasts of 14% per year, comfortably beating the broader US auto components sector's 10.5% growth outlook. Earnings are predicted to accelerate even faster, with EPS expected to expand 30.7% per year, well ahead of the market's 16% annual average. Meanwhile, the current net profit margin edged down to 10.8% from last year's 11.6%. The combination of robust forecasted growth, a share price trading below estimated fair value at $35.31 per share, and...

Thinking of investing in BancFirst and wondering if the stock is truly undervalued, or if there is more to the story? You are not alone. Many savvy investors are taking a closer look at its numbers. BancFirst shares have been on a wild ride, rising 1.1% in the last week, despite dropping 13.0% over the past month and showing a year-to-date decline of 4.7%. However, if you zoom out, they are still up 130.4% over the past five years. Much of this recent volatility is linked to news around...

Ovintiv (OVV) has achieved an average annual earnings growth of 49.2% over the past five years. However, the latest 12 months saw net profit margin shrink to 6.6% from 18.8% in the previous year. Results for the period include a notable one-off loss of $1.2 billion, which weighed on reported earnings. Looking ahead, revenue is forecast to rise 2.8% per year, trailing the broader US market's expected 10.5% annual growth. Meanwhile, earnings are projected to climb 39.8% per year, outpacing the...

Taboola (TBLA) has turned profitable for the first time, with its net profit margin showing clear improvement over the past year. The company’s earnings are forecast to grow at an impressive 32.4% per year, more than double the US market’s average, while revenue is expected to grow at 6.9% annually, trailing the broader market’s 10.5%. Shares recently traded at $3.71, which is well below an estimated fair value of $10.05. The current Price-To-Earnings Ratio stands at a hefty 80.9x, indicating...

Avadel Pharmaceuticals (AVDL) continues to operate at a loss, with losses having grown at an average annual rate of 12.4% over the past five years and a net profit margin that remains unimproved year over year. Despite its current lack of profitability, Avadel’s revenue is forecast to climb 15.6% annually, which is ahead of the broader US market’s 10.5%. Earnings are projected to surge by 40.12% each year. The company is anticipated to reach profitability within three years, and with its...

Wheels Up Experience (UP) remains unprofitable, with losses widening at an annual rate of 21.3% over the past five years. Margins have shown no signs of recovery, and profitability is still in the red. With a Price-to-Sales Ratio of 1.1x, the company trades at a premium compared to both its peers (0.4x) and the industry average (0.5x), which further underscores caution around its current valuation. See our full analysis for Wheels Up Experience. The next section puts these earnings numbers...

O-I Glass (OI) has posted widening losses, with net losses rising at an annual rate of 39.2% over the past five years. Looking ahead, analysts expect a dramatic turnaround for the company. Earnings are forecast to grow 65.89% per year, with profitability expected within the next three years. This growth rate outpaces the broader US market. See our full analysis for O-I Glass. Next up, we'll see how these results compare to the prevailing narratives, revealing where numbers match expectations...

Voya Financial (VOYA) reported revenue growth projections of 4.4% per year and expects annual EPS to rise 13.5%, both lagging behind the broader US market’s respective averages of 10.5% and 16%. Current net profit margin is 6.2%, down from 10.4% a year ago, and earnings have declined on average by 14.9% annually over the past five years. With these margin and growth headwinds, investor focus is likely to remain fixed on Voya’s discounted valuation, robust earnings quality, and attractive...

Essential Utilities (WTRG) reported annual earnings growth of 7.5% and revenues forecast to rise 5.7% per year. Both figures are running below US market averages of 16% for revenue and 10.5% for earnings. Current net profit margins sit at 27.6%, just shy of last year’s 28.7%. The company’s five-year profit growth rate of 13.2% and a recent earnings jump of 16% demonstrate some resilience. A price-to-earnings ratio of 17.2x places shares below peer averages, even as the current share price...

DMC Global (BOOM) recorded a continued rise in net losses, with the bottom line deteriorating at an annual rate of 65.5% over the past five years, and no improvement in net profit margin. At the same time, shares are trading well below fair value at $6.25, compared to an estimated fair value of $13.29. The company's price-to-sales ratio stands at just 0.2x, significantly undercutting both the US Energy Services industry and its peers. While the persistent unprofitability and weak margins are...

Horace Mann Educators (HMN) posted a notable turnaround in its latest results, with EPS margins climbing to 8.5% compared to 5.2% last year, and a dramatic 71.9% earnings growth over the prior period. This reverses a five-year trend of 14.4% annual declines. However, the revenue outlook is more subdued, with future growth expected at 5.7% per year, which lags behind the broader US market pace of 10.5%. The company’s improvement in profitability and rising EPS provide a positive setup for...

Supernus Pharmaceuticals (SUPN) posted a jump in net profit margin to 9.7%, a substantial leap from just 0.8% a year earlier, while annual earnings soared by 1131.1%, far ahead of its 5-year average of minus 27% per year. With forecasts calling for 54% earnings growth and 14.6% revenue growth per year, and analysts highlighting high quality earnings, investors are taking a hard look at the company’s momentum. As shares continue to trade below analyst price targets, much of the conversation...

NeuroPace (NPCE) remains unprofitable, but recent progress on the bottom line includes losses shrinking by 2.2% per year over the past five years. Forecasts show revenue is on track to grow 14.9% annually with earnings expected to rise at a rapid 64.52% per year. Analysts anticipate the company will reach profitability within three years. These trends suggest that while the margin story is still developing, improving financials point to potential upside for investors keeping an eye on...

Baldwin Insurance Group (BWIN) remains unprofitable, with losses having grown at an annualized rate of 22.7% over the past five years. Looking ahead, analysts expect earnings to surge at 81.77% per year and revenue growth of 11% annually, both outpacing the broader US market. The key message for investors is the possibility of significant profit and revenue growth in the coming periods, which would be a notable shift from the company’s history of mounting losses. See our full analysis for...

Centessa Pharmaceuticals (CNTA) is forecast to deliver stellar annual revenue growth of 74.3%, far surpassing the broader US market’s 10.5% pace. Despite the robust top-line outlook, the company remains unprofitable and is expected to continue operating at a loss over the next three years. While losses have narrowed at an average rate of 4.3% per year over the past five years, there are no signs of an imminent shift toward profitability. This raises the stakes for investors weighing rapid...

Frontdoor (FTDR) delivered robust earnings growth of 24.8% over the past year, comfortably ahead of its five-year average of 21.2% annually. Net profit margins expanded to 13.1% from 11.4% last year, and the company maintained consistently high-quality earnings throughout this period. Looking forward, Frontdoor’s modest growth outlook and classification as good value, against a slightly discounted share price, position operational strength and improved margins at the forefront for investors...